TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
BCYC

Bicycle Therapeutics Ltd

Healthcare · Biotechnology

3.70$ -1.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement BCYC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – +246.4% +93.4% -24.7% +12.6% +23.6% +86.5% +30.8% +105.8%
– +4,306.4% +75.0% +23.0% +29.8% +35.4% -91.8% +4,144.9% +10.5% -96.3%
– – – – -264.9% – +23.6% -995.5% – –
– +21.4% +75.0% +23.0% +29.8% +35.4% +81.8% +91.8% +10.5% +38.9%
– +69.6% +26.8% +79.3% +100.6% +11.1% +52.6% +20.9% +19.4% +12.0%
– +38.2% +58.1% +38.8% -27.2% +164.8% +69.6% -53.9% +19.5% +343.8%
– – – – – – – – – –
– – – – -87.3% +553.0% +12.1% -2.4% -47.0% -88.1%
– – – – – – – – – –
– – – – – – – – -427.0% –
– – – – – – – – – –
– – – – – – – – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?